A timely medical intervention in the form of a bone marrow transplant, medically known as hematopoietic stem cell ...

Here, we reviewed the recent literature regarding the clinical significance of the influenza virus infection ... hematopoietic stem-cell transplant (HSCT) recipients, and patients receiving ...

FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...

WHO declared the start of the COVID-19 pandemic. Although patients with haematological malignancies have greatly benefited ...

designed to protect patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) from infections, and other oral microbiome therapies in its pipeline. SER-155 is currently in the ...

Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...

Theoretically, HSCT offers 2 major advantages in the treatment ... During the first part of this phase, the major problems encountered are infections from endogenous bacteria, the reactivation ...

Seres Therapeutics (MCRB) announced that it has received constructive feedback from a Type B Breakthrough Therapy designation engagement with ...

Zydus Lifesciences announced that it has launch ANVIMO (Letermovir), a new and innovative treatment for the prevention of Cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) ...